ZENSARTECH - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.0
| Stock Code | ZENSARTECH | Market Cap | 11,687 Cr. | Current Price | 514 ₹ | High / Low | 895 ₹ |
| Stock P/E | 16.6 | Book Value | 155 ₹ | Dividend Yield | 2.53 % | ROCE | 26.5 % |
| ROE | 21.3 % | Face Value | 2.00 ₹ | DMA 50 | 573 ₹ | DMA 200 | 668 ₹ |
| Chg in FII Hold | -1.29 % | Chg in DII Hold | 0.54 % | PAT Qtr | 199 Cr. | PAT Prev Qtr | 181 Cr. |
| RSI | 36.8 | MACD | -8.48 | Volume | 5,52,187 | Avg Vol 1Wk | 7,13,726 |
| Low price | 511 ₹ | High price | 895 ₹ | PEG Ratio | 0.49 | Debt to equity | 0.01 |
| 52w Index | 0.78 % | Qtr Profit Var | 35.6 % | EPS | 30.2 ₹ | Industry PE | 21.6 |
📊 Financials: ZENSARTECH demonstrates strong efficiency with ROCE at 26.5% and ROE at 21.3%, reflecting excellent capital utilization. Debt-to-equity ratio is very low (0.01), ensuring financial stability. EPS of ₹30.2 supports profitability, while quarterly PAT improved (₹181 Cr → ₹199 Cr, +35.6%), highlighting consistent growth momentum.
💹 Valuation: Current P/E of 16.6 is below industry average (21.6), suggesting undervaluation. PEG ratio of 0.49 indicates attractive growth prospects at reasonable valuations. P/B ratio (~3.3) is fair relative to book value. Dividend yield of 2.53% adds income support for investors.
🏢 Business Model & Advantage: ZENSARTECH operates in IT services and digital solutions, benefiting from global demand for outsourcing and transformation. Competitive advantage lies in strong efficiency metrics, low leverage, and consistent profitability, though foreign investor sentiment has weakened.
📈 Entry Zone: Attractive accumulation near ₹500–₹530 (close to support levels). Current price (₹514) is undervalued relative to fundamentals, with resistance at ₹650–₹700.
⏳ Long-Term Holding: Strong candidate for 3–5 year horizon given superior fundamentals, undervaluation, and dividend yield. Partial profit booking advised near ₹650–₹700 resistance zones.
Positive
- Strong ROCE (26.5%) and ROE (21.3%)
- Low debt-to-equity (0.01)
- EPS of ₹30.2 supports profitability
- Dividend yield of 2.53% adds investor appeal
- Quarterly PAT growth (+35.6%)
Limitation
- FII holdings decreased (-1.29%), showing weaker foreign confidence
- Stock trading below DMA 200 (₹668), indicating technical weakness
- 52-week performance (0.78%) is modest compared to peers
Company Negative News
- Decline in FII holdings (-1.29%)
- Technical weakness with price below DMA 200
Company Positive News
- DII holdings increased (+0.54%), showing domestic institutional support
- Quarterly profit growth (+35.6%) highlights operational strength
Industry
- Industry P/E at 21.6 reflects moderate sector valuation
- ZENSARTECH trades at a discount compared to peers, offering value opportunity
Conclusion
ZENSARTECH is fundamentally strong with excellent efficiency, low debt, and attractive dividend yield. Entry is ideal near ₹500–₹530, with profit booking advised near ₹650–₹700. Long-term investors can hold for 3–5 years, benefiting from undervaluation and consistent profitability.